These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30686997)

  • 1. UBE3A: An E3 Ubiquitin Ligase With Genome-Wide Impact in Neurodevelopmental Disease.
    Lopez SJ; Segal DJ; LaSalle JM
    Front Mol Neurosci; 2018; 11():476. PubMed ID: 30686997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.
    Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM
    Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
    LaSalle JM; Reiter LT; Chamberlain SJ
    Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons.
    Lopez SJ; Dunaway K; Islam MS; Mordaunt C; Vogel Ciernia A; Meguro-Horike M; Horike SI; Segal DJ; LaSalle JM
    Epigenetics; 2017; 12(11):982-990. PubMed ID: 28925810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase
    Shi SQ; Mahoney CE; Houdek P; Zhao W; Anderson MP; Zhuo X; Beaudet A; Sumova A; Scammell TE; Johnson CH
    Front Behav Neurosci; 2022; 16():837523. PubMed ID: 35401134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene
    Sato M
    Front Cell Neurosci; 2017; 11():62. PubMed ID: 28326016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of UBE3A in the autism and epilepsy-related Dup15q syndrome using patient-derived, CRISPR-corrected neurons.
    Elamin M; Dumarchey A; Stoddard C; Robinson TM; Cowie C; Gorka D; Chamberlain SJ; Levine ES
    Stem Cell Reports; 2023 Apr; 18(4):884-898. PubMed ID: 36898382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic approaches for Angelman syndrome.
    Bi X; Sun J; Ji AX; Baudry M
    Expert Opin Ther Targets; 2016; 20(5):601-13. PubMed ID: 26558806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome.
    Yi JJ; Paranjape SR; Walker MP; Choudhury R; Wolter JM; Fragola G; Emanuele MJ; Major MB; Zylka MJ
    J Biol Chem; 2017 Jul; 292(30):12503-12515. PubMed ID: 28559284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ubiquitin ligase E3A in polarized contact guidance and rescue strategies in UBE3A-deficient hippocampal neurons.
    Tonazzini I; Van Woerden GM; Masciullo C; Mientjes EJ; Elgersma Y; Cecchini M
    Mol Autism; 2019; 10():41. PubMed ID: 31798818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions.
    Khatri N; Man HY
    Front Mol Neurosci; 2019; 12():109. PubMed ID: 31114479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
    Musi CA; Agrò G; Buccarello L; Camuso S; Borsello T
    Neurobiol Dis; 2020 Jul; 140():104812. PubMed ID: 32087286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
    Low D; Chen KS
    Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies.
    Roy B; Amemasor E; Hussain S; Castro K
    Diseases; 2023 Dec; 12(1):. PubMed ID: 38248358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HECT E3 Ligase E6AP/UBE3A as a Therapeutic Target in Cancer and Neurological Disorders.
    Owais A; Mishra RK; Kiyokawa H
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angelman syndrome: advancing the research frontier of neurodevelopmental disorders.
    Philpot BD; Thompson CE; Franco L; Williams CA
    J Neurodev Disord; 2011 Mar; 3(1):50-6. PubMed ID: 21484597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bipartite boundary element restricts
    Hsiao JS; Germain ND; Wilderman A; Stoddard C; Wojenski LA; Villafano GJ; Core L; Cotney J; Chamberlain SJ
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2181-2186. PubMed ID: 30674673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Scalable, Cell-based Method for the Functional Assessment of Ube3a Variants.
    Stelzer JA; Yi JJ
    J Vis Exp; 2022 Oct; (188):. PubMed ID: 36282706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila.
    Li W; Yao A; Zhi H; Kaur K; Zhu YC; Jia M; Zhao H; Wang Q; Jin S; Zhao G; Xiong ZQ; Zhang YQ
    PLoS Genet; 2016 May; 12(5):e1006062. PubMed ID: 27232889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.
    Lee SY; Ramirez J; Franco M; Lectez B; Gonzalez M; Barrio R; Mayor U
    Cell Mol Life Sci; 2014 Jul; 71(14):2747-58. PubMed ID: 24292889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.